Navigation Links

Biology Technology

PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks

3/30/2015
Winston-Salem, NC (PRWEB) March 30, 2015 PMG Research, Benchmark Research, and Miami Research Associates are pleased to announce the formation of VaxCorps, a network of highly experienced, geographically diverse clinical research centers specializing in the conduct of vaccine trials in healthy adult, elderly, and pediatric populations. VaxCorps clinical sites have successfully conducted ov... [Comments]

New Findings Support the Benefits of Eating Walnuts on Overall Health

3/30/2015
FOLSOM, Calif. , March 30, 2015  Multiple new research abstracts suggest walnuts may have the potential to positively affect several important health factors. From their impact on colon cancer and certain aspects of cognitive aging, to their positive effect on both gut health and vascular health, the research findings presented at Experimental Biology 2015 (EB) detail our... [Comments]

Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice

3/30/2015
CHICAGO , March 30, 2015  Heidrick & Struggles (Nasdaq: HSII ), the premier provider of executive search , leadership consulting and culture shaping worldwide, today  announced that John Mitchell has joined the firm to lead its global Healthcare and Life Sciences practice. As Global Practice Managing Partner – Healthcare and Life Sciences, Mitchell... [Comments]

UCI Professor Zhibin Guan Joins NuGene Advisory Board

3/30/2015
IRVINE, Calif. , March 30, 2015  NuGene International, Inc. ("NuGene") (OTCQB: NUGN), announced today that its subsidiary corporation, NuGene BioPharma, Inc. has added another internationally recognized researcher to its advisory board. Dr. Guan is an internationally recognized researcher in bio-inspired materials and bio-materials fields. After finishing his college edu... [Comments]

New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey

3/30/2015
NEW BRUNSWICK, N.J. , March 30, 2015  New Jersey Health Foundation, a not-for-profit organization that funds research and innovation projects in the state of New Jersey , has committed $1 million to its next round of grant funding, announced James M. Golubieski , president. Through its existing New Jersey Health Foundation Research Grants program, an addit... [Comments]

Yale University and Novogen Release Data on Cantrixil Mode of Action

3/30/2015
SYDNEY , March 30, 2015 US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ: NVGN ) and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62 nd Annual Scientific Meeting... [Comments]

CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma

3/30/2015
ROCKVILLE, Md. , March 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China , announced today that the China Food and Drug Administration (CFDA) has appr... [Comments]

New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices

3/30/2015
OTTAWA , March 30, 2015 /CNW/ - A new national Labour Market Information (LMI) report was released today on the salaries and demographic profiles of new graduates entering the biotech sector. The BioTalent Canada report, "Opening the Door – Building Careers for New Grads in Biotech," is sponsored in part by Canada's Research-Based Pharmaceutical Companies (Rx&D) and features dat... [Comments]

Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy

3/30/2015
GERMANTOWN, Md. , March 30, 2015    Intrexon Corporation (NYSE: XON ), a leader in synthetic biology, and Merck Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany , today announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. This collaborat... [Comments]

Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon

3/30/2015
BETHESDA, Md. , March 30, 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update regarding  Spherix v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. Uniden , Case No. 3:13-cv-03496-M, both in the United States Distr... [Comments]

Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics

3/30/2015
CARDIFF, UK, and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 A two-day workshop on laser energy projects in Europe and the United States and plenary talks by four leading photonics researchers are among programme highlights planned for SPIE Optics + Optoelectronics next month in Prague, Czech Republic. The symposium will feature over 700 technical presentations in 17 conferences al... [Comments]

Medicine Technology

Colposcope Market: 2015 - 2020 Global Manufacturers, Suppliers, Trend Analysis

3/30/2015
DALLAS , March 30, 2015 LifeScienceIndustryResearch.com announces 2015 Market Research Report on Global Colposcope Industry spread across 178 pages is available for purchase at USD 2600 (Single User PDF).  This is a professional and deep research report in this field. For overview analysis, the report introduces Colposcope basic information including definition, class... [Comments]

Severe Alzheimer's Patient Responds to Bryostatin Treatment

3/30/2015
MORGANTOWN, W. Va. , March 30, 2015  Researchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD."  An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PS... [Comments]

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B

3/30/2015
IRVINE, Calif. , March 30, 2015  EP Global Communications, Inc. (OTC-PINK: EPGL) In a new material development to shareholders, EPGL has opened negotiations with CooperVision, Inc. at $1.1 billion for the exclusive Option to License their new ophthalmic technologies. As previously disclosed publicly, CooperVision, Inc. and EP Global Communications, Inc. have co-develo... [Comments]

Preparation Is Personal for Those with Chronic Illnesses

3/30/2015
AUSTIN, Texas , March 30, 2015 News Highlights: .@TheAACE and @LillyDiabetes highlight the My Diabetes Emergency Plan at the 2015 @NatHurricaneCon .@TheAACE and @LillyDiabetes at @NatHurricaneCon to encourage you to be prepared to manage your #diabetes before emergencies strike The American College of Endocrinology (ACE) – the charitable, educational and scien... [Comments]

Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver

3/30/2015
DUBLIN , Mar. 26, 2015 Research and Markets ( http://www.researchandmarkets.com/research/dn2ldn/computer_aided ) has announced the addition of the "Computer Aided Detection (CAD) - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a six-year historic analysis is provided for thes... [Comments]

New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms

3/30/2015
NORTHRIDGE, Calif. , March 30, 2015  The investigational S- equol nutritional supplement may be a viable agent to alleviate certain menopause symptoms, such as hot flashes, according to a new peer-reviewed article in the March Journal of Women's Health .[i] "Current data suggest that women may have benefits with S- equol for menopausal vasomotor symptoms and possibly... [Comments]

Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015

3/30/2015
NEW YORK , March 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), a clinical stage medical diagnostics company focused on the development of a preparation-free ingestible imaging capsule that utilizes low-dose X-rays for the screening for colorectal cancer, announced today that its CEO, Guy Neev , will ring the closing bell of the March 31, 2015 trading day.  Neev and... [Comments]

Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company

3/30/2015
WHITE PLAINS, N.Y. , March 30, 2015  A promising University of Michigan research project focused on developing new treatments for patients with a rare and lethal subtype of leukemia has received a significant boost from a recent licensing agreement with a new biotechnology company, Kura Oncology.  The Leukemia & Lymphoma Society (LLS) has been funding t... [Comments]

MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations

3/30/2015
WYNNEWOOD, Pa. , March 30, 2015  Building on the momentum of the first quarter of 2015, MedScope ( www.medscope.org ), the leading provider of medical alert systems, has announced aggressive plans to expand its Medicaid Home and Community Based Waiver Services (HCBS) program and Managed Care business models. The first quarter addition of new contracts in Texas , Ten... [Comments]

Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement

3/30/2015
MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015  Uroplasty, Inc. (NASDAQ: UPI ) and Vision-Sciences, Inc. (NASDAQ: VSCI ) shareholders have voted at the special meeting of each company's shareholders held today to approve the previously announced agreement and plan of merger between the two companies. "We are pleased with the outcome of today's special meet... [Comments]

Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage

3/30/2015
DUBLIN , Mar. 26, 2015 Research and Markets ( http://www.researchandmarkets.com/research/j8nwnz/urological ) has announced the addition of the "Urological Catheters - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Urological Catheters in Thousand Units and US$ Thousands by the following Product Segments: Dialysis... [Comments]

(Date:3/30/2015)... 30, 2015 US-Australian drug discovery company, Novogen ... CanTx, Inc., and Yale University, on March 27 released ... was presented as an oral presentation by Professor ... to the 62 nd Annual Scientific Meeting of ... Francisco, CA. In both in ...
(Date:3/30/2015)... CARDIFF, UK, and BELLINGHAM, Washington, USA (PRWEB) March 29, ... energy projects in Europe and the United States and ... programme highlights planned for SPIE Optics + Optoelectronics ... will feature over 700 technical presentations in 17 conferences ... international society for optics and photonics , the event ...
(Date:3/29/2015)... IRVING, Texas , March 29, 2015 /PRNewswire/ ... two studies in which Caris Molecular Intelligence®, the ... molecular similarities and differences between several rare and ... treatment strategies that have the potential to improve ... Poster Session B at the Society of Gynecologic ...
(Date:3/27/2015)... The consumption of compound fertilizers (NPK) ... and high prices in 2008. However, the situation has ... on gaining momentum now. , To date, the world ... 100,000 thousand tonnes. No considerable growth was registered in ... rocketed during 2012-2013, registering 11% growth as against the ...
Breaking Biology Technology:Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3
... manufactured from bone marrow; SV Life ... LAKE CITY and HAMBURG, Germany, July 2 AlloCure,Inc., ... therapies,for the treatment of acute kidney injury, today announced ... was led by SV Life Sciences with Novo,A/S joining ...
... Expanded Portfolio of Vascular ... ... Inc. (TSXV:,NVC), formerly Medical Ventures Corp. (TSXV: MEV), a company developing ... expansion of its product portfolio, as the company completed,the acquisition of ...
... Schering-Plough,Corporation (NYSE: SGP ) today ... transaction with Virbac, S.A. to divest animal ... requested by the,European Commission as part of ... Organon BioSciences N.V., In Europe, Virbac ...
Cached Biology Technology:AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... Calif. , March 30, 2015  The investigational ... agent to alleviate certain menopause symptoms, such as hot ... March Journal of Women,s Health .[i] ... S- equol for menopausal vasomotor symptoms and possibly ... supporting safety of S- equol, physicians and health ...
(Date:3/30/2015)... March 30, 2015  A promising University of Michigan ... with a rare and lethal subtype of leukemia has ... with a new biotechnology company, Kura Oncology.  The Leukemia ... led by Assistant Professor Jolanta Grembecka , Ph.D, ... the University of Michigan, since 2009. ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3
... A unique treatment involving the use of hot chemotherapy ... Center. SJH&MC is the first hospital in Southeast Michigan ... offer the treatment. Know as Hyperthermic Intraperitoneal ... number of advanced cancers that have spread to the ...
... and SYDNEY, Nov. 4, 2011 HeartWare International, Inc. ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... 11:00 a.m. MST on Wednesday, November 9, 2011.  The ...
Cached Medicine Technology:St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System 2HeartWare to Present at the Credit Suisse 2011 Healthcare Conference 2